Garden State Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

Garden State Investment Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$297K	Sell	2,130 -201	-9%	-$28.1K	0.07%	229
2025 Q4	$286K	Sell	2,331 -345	-13%	-$41.9K	0.06%	237
2025 Q3	$297K	Sell	2,676 -5	-0.2%	-$568	0.07%	224
2025 Q2	$297K	Buy	2,681 +5	+0.2%	+$532	0.08%	224
2025 Q1	$300K	Buy	2,676 +5	+0.2%	+$516	0.1%	188
2024 Q4	$247K	Buy	2,671 +38	+1%	+$3.42K	0.07%	213
2024 Q3	$221K	Buy	+2,633	New	+$201K	0.07%	206
2024 Q1	–	Sell	-2,918	Closed	-$236K	–	259
2023 Q4	$236K	Buy	+2,918	New	+$227K	0.09%	176

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Garden State Investment Advisory Services's GILD Position: Q1 2026 in Review

Garden State Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 8.6% in Q1 2026, selling an estimated $28.1K and leaving 2,130 shares worth $297K. The position accounts for 0.07% of the portfolio, ranked #229.

Garden State Investment Advisory Services first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. The position peaked at $300K in Q1 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Garden State Investment Advisory Services held 2,130 shares of Gilead Sciences worth $297K as of Q1 2026.
Garden State Investment Advisory Services sold 201 Gilead Sciences shares in Q1 2026, an estimated $28.1K.
Gilead Sciences made up 0.07% of Garden State Investment Advisory Services's portfolio in Q1 2026, its #229 holding.
Garden State Investment Advisory Services first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
Garden State Investment Advisory Services's Gilead Sciences position peaked at $300K in Q1 2025.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q1 2026, filed 14 May 2026.